Compare Globus Medical Inc. Class A Common Stock (GMED) vs Noble Corporation plc (NE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Noble Corporation plc — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Noble Corporation plc trades at $42.9 (market cap $6.85B). The key difference: Globus Medical Inc. Class A Common Stock is the larger of the two by market cap, and Noble Corporation plc pays a 4.66% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Noble Corporation plc for 27 Days on average.
| GMED | NE | |
|---|---|---|
Market Cap | $10.25B | $6.85B |
Volume | 1,059,528 | 984,361 |
Sector | Health | Energy |
52-Week High | $96.82 | $54.37 |
52-Week Low | $58.33 | $27.45 |
Typical Hold Time | 0 Days | 27 Days |
Enterprise Value | $9.76B | $8.28B |
Dividend Yield | — | 4.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Noble Corporation (NE) trades at $43.42, up 1.12% today. The stock shows mixed signals with a bullish technical outlook but bearish moving averages. Recent earnings have been volatile, with Q1 2026 beating expectations but Q2 and Q4 2025 missing. Revenue declined from $3.3B in 2025 to $3.1B in 2026, and net income fell from $217M to $150M. Positive news includes a long-term drilling contract in Ghana, but the company faces an ongoing law firm investigation.
Outlook is cautious. The consensus price target of $52.00 implies potential upside, supported by a 'Buy' rating from 31% of analysts. However, declining profitability, mixed earnings history, and legal scrutiny present risks. Investors should weigh contract wins against fundamental pressures and sentiment headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Noble Corporation plc
Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →
